Ophthalmology · Plantation, FL
NPI
1841527710
Since 2009
Specialty
Ophthalmology
Code 207W00000X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
1776 N Pine Island Rd, Suite 214
Plantation, FL, 33322
Phone (954) 452-9922
Groups this clinician bills Medicare through
Medicare paid, 2024
$446K
12,131 services
Medicare patients, 2024
786
Average age 77
Drug cost, 2024
$2.0M
4,457 prescriptions
Company payments, 2025
$9,314
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anil S Vedula was code 95004 (test - miscellaneous), 7,080 times for 116 patients. In total Anil S Vedula billed 12,131 services in 51 codes, and Medicare paid $446K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 7,080 | 116 | $3.22 | $23K |
| 92014 Ophthalmological E&M | Office | 981 | 549 | $90.42 | $89K |
| 92134 Computerized Ophthalmic Imaging | Office | 707 | 517 | $29.71 | $21K |
| 76512 Ultrasound - Nonspecific | Office | 443 | 404 | $70.33 | $31K |
| 92083 Vision, Hearing, and Speech Services | Office | 306 | 277 | $47.55 | $15K |
| 92133 Computerized Ophthalmic Imaging | Office | 248 | 227 | $25.58 | $6,344 |
| 92012 Ophthalmological E&M | Office | 243 | 141 | $68.15 | $17K |
| 68761 Eye | Office | 189 | 58 | $86.57 | $16K |
| 92004 Ophthalmological E&M | Office | 158 | 158 | $102.68 | $16K |
| 92250 Angiography | Office | 143 | 128 | $28.10 | $4,018 |
| 66984 Cataract Surgery | Facility | 126 | 84 | $430.21 | $54K |
| 92136 Ultrasound - Nonspecific | Office | 103 | 103 | $36.90 | $3,800 |
| 67028 Intravitreal Injection | Office | 58 | 16 | $87.14 | $5,054 |
| 92285 Standard X-ray | Office | 53 | 41 | $17.87 | $947 |
| 65778 Eye | Office | 50 | 34 | $861.88 | $43K |
By year: 2022 $371K for 8,138 services; 2023 $426K for 10,345 services; 2024 $446K for 12,131 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anil S Vedula prescribed most often to Medicare patients was Prednisolone Acetate, with 666 prescriptions and refills. In total Anil S Vedula wrote 4,457 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 666 | 847 | 467 | $32K |
| Moxifloxacin Moxifloxacin Hcl | 517 | 520 | 415 | $10K |
| Ketorolac Tromethamine Generic | 410 | 547 | 337 | $12K |
| Xiidra Lifitegrast | 392 | 544 | 195 | $290K |
| Restasis Cyclosporine | 331 | 410 | 156 | $243K |
| Latanoprost Generic | 259 | 479 | 92 | $2,005 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 195 | 367 | 64 | $2,599 |
| Lumigan Bimatoprost | 192 | 386 | 73 | $107K |
| Eysuvis Loteprednol Etabonate | 114 | 131 | 106 | $55K |
| Brimonidine Tartrate Generic | 102 | 185 | 36 | $1,823 |
| Cequa Cyclosporine | 96 | 102 | 61 | $61K |
| Loteprednol Etabonate Generic | 95 | 117 | 77 | $17K |
| Rhopressa Netarsudil Mesylate | 90 | 117 | 24 | $33K |
| Timolol Maleate Generic | 81 | 163 | 34 | $1,323 |
| Ilevro Nepafenac | 62 | 84 | 38 | $23K |
Brand drugs: 2,692 claims; generic drugs: 1,765 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anil S Vedula $9,314 ($9,314 in general payments such as food, travel and fees) from 17 companies. The largest payer was Biotissue Holdings Inc. with $5,452.
| Company | Payments | Amount |
|---|---|---|
| Biotissue Holdings Inc. | 25 | $5,452 |
| Alcon Vision LLC ALC | 29 | $1,003 |
| Abbvie Inc. ABBV | 33 | $729 |
| Sight Sciences, Inc. SGHT | 8 | $603 |
| New World Medical,Inc. | 8 | $428 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 11 | $270 |
| Bausch & Lomb Americas Inc. BLCO | 13 | $191 |
| Glaukos Corporation GKOS | 4 | $152 |
| Johnson & Johnson Surgical Vision, Inc. JNJ | 3 | $87.79 |
| Tarsus Pharmaceuticals, Inc. TARS | 3 | $79.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.